Dennis L. Ryll serves as Executive at ACCENTIA BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Dennis L. Ryll has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 13, 2006 involved gifting 1,000 shares valued at $0.
Dennis L. Ryll currently holds 3,617,660 shares of ACCENTIA BIOPHARMACEUTICALS INC (ABPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis L. Ryll has been a net neutral trader of ABPI stock. They have purchased $0 and sold $0 worth of shares.
Dennis L. Ryll's most recent insider trade was on Sep 13, 2006, when they sold 1,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 3, 2006 | ABPI | $42.7K | Other | 5,339 | $8.00 | Discretionary |
| Apr 3, 2006 | ABPI | $2.0K | Other | 252 | $8.00 | Discretionary |
| Mar 2, 2006 | ABPI | $0 | Gift | 4,000 | $N/A | Discretionary |
| Mar 1, 2006 | ABPI | $0 | Gift | 2,000 | $N/A | Discretionary |
| Feb 28, 2006 | ABPI | $0 | Gift | 9,500 | $N/A | Discretionary |